Multicenter comparison of laboratory performance in cytomegalovirus and Epstein-Barr virus viral load testing using international standards

Clinical Transplantation

Volumn 28, Issue 12, 2014, Pages 1416-1423

  Rychert, Jenna ^a   Danziger Isakov, Lara ^b   Yen Lieberman, Belinda ^c   Storch, Gregory ^d   Buller, Richard ^d   Sweet, Stewart C ^d   Mehta, Aneesh K ^e,f   Cheeseman, Jennifer A ^e   Heeger, Peter ^g   Rosenberg, Eric S ^a   Fishman, Jay A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e EMORY UNIVERSITY   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical trial; Cytomegalovirus; Epstein Barr virus; Quantitative nucleic acid testing; Viral load; WHO standards

Indexed keywords

ARTICLE; CLINICAL LABORATORY; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; HUMAN; INTERMETHOD COMPARISON; MULTICENTER STUDY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; QUALITATIVE RESEARCH; TASK PERFORMANCE; VIRAL LOAD TESTING; VIRUS LOAD; WORLD HEALTH ORGANIZATION; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CYTOMEGALOVIRUS INFECTIONS; DIAGNOSTIC KIT; EPSTEIN-BARR VIRUS INFECTIONS; GENETICS; INTERNATIONAL COOPERATION; ISOLATION AND PURIFICATION; LABORATORY; POLYMERASE CHAIN REACTION; PROCEDURES; STANDARD; STANDARDS; VIROLOGY;

DIAGNOSTIC KIT; VIRUS DNA;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; INTERNATIONAL AGENCIES; LABORATORIES; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; REFERENCE STANDARDS; VIRAL LOAD;

EID: 84918839424     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12473     Document Type: Article

References (19)

1. Andrews PA, Emery VC, Newstead C. Summary of the British Transplantation Society guidelines for the prevention and management of CMV disease after solid organ transplantation. Transplantation 2011: 92: 1181.
2. de la Torre-Cisneros J, Farinas MC, Caston JJ et al. GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients. Enferm Infecc Microbiol Clin 2011: 29: 735.
3. Hadaya K, Wunderli W, Deffernez C et al. Monitoring of cytomegalovirus infection in solid-organ transplant recipients by an ultrasensitive plasma PCR assay. J Clin Microbiol 2003: 41: 3757.
4. Humar A, Gregson D, Caliendo AM et al. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation 1999: 68: 1305.
5. Humar A, Snydman D; Practice ASTIDCo. Cytomegalovirus in solid organ transplant recipients. Am J Transplant 2009: 9(Suppl 4): S78.
6. Kraft CS, Armstrong WS, Caliendo AM. Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective. Clin Infect Dis 2012: 54: 1793.
7. Le PA, Jager MM, Kotton CN, Simoons-Smit A, Rawlinson WD. International Survey of Cytomegalovirus Management in Solid Organ Transplantation After the Publication of Consensus Guidelines. Transplantation 2013: 95: 1455.
8. Bravo D, Clari MA, Costa E et al. Comparative evaluation of three automated systems for DNA extraction in conjunction with three commercially available real-time PCR assays for quantitation of plasma cytomegalovirus DNAemia in allogeneic stem cell transplant recipients. J Clin Microbiol 2011: 49: 2899.
9. Caliendo AM, Ingersoll J, Fox-Canale AM et al. Evaluation of real-time PCR laboratory-developed tests using analyte-specific reagents for cytomegalovirus quantification. J Clin Microbiol 2007: 45: 1723.
10. Pang XL, Fox JD, Fenton JM et al. Interlaboratory comparison of cytomegalovirus viral load assays. Am J Transplant 2009: 9: 258.
11. Preiksaitis JK, Pang XL, Fox JD et al. Interlaboratory comparison of Epstein-Barr virus viral load assays. Am J Transplant 2009: 9: 269.
12. Hayden RT, Hokanson KM, Pounds SB et al. Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus. J Clin Microbiol 2008: 46: 157.
13. Ito Y, Takakura S, Ichiyama S et al. Multicenter evaluation of prototype real-time PCR assays for Epstein-Barr virus and cytomegalovirus DNA in whole blood samples from transplant recipients. Microbiol Immunol 2010: 54: 516.
14. Gouarin S, Vabret A, Scieux C et al. Multicentric evaluation of a new commercial cytomegalovirus real-time PCR quantitation assay. J Virol Methods 2007: 146: 147.
15. Fryer JF, Heath AB, Anderson R, Minor PD; the Collaborative Study Group. Collaborative Study to Evaluate the Proposed 1st WHO International Standard for Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification (NAT)-Based Assays. Geneva: Standardization ECoB, 2010.
16. Fryer JF, Heath AB, Wilkinson DE, Minor PD; the collaborative study group. Collaborative Study to Evaluate the Proposed 1st WHO International Standard for Epstein-Barr virus (EBV) for Nucleic Acid Amplification (NAT)-based Assays. Available at: http://www.who.int/handle/10665/70781, 2011.
17. Kotton CN. Management of cytomegalovirus infection in solid organ transplantation. Nat Rev Nephrol 2010: 6: 711.
18. Preiksaitis JK, Brennan DC, Fishman J, Allen U. Canadian Society of Transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report. Am J Transplant 2005: 5: 218.
19. Caliendo AM, Shahbazian MD, Schaper C et al. A commutable cytomegalovirus calibrator is required to improve the agreement of viral load values between laboratories. Clin Chem 2009: 55: 1701.